STRATEC Biomedical AG
Closed
16.72 -5.54
Overview
Share price change
24h
Min
16.5
Max
17.7
Income | -5.8M -4.3M |
|---|---|
Sales | 18M 75M |
P/E Sector Avg | 14.63 26.79 |
EPS | -0.357 |
Profit margin | -5.772 |
Employees | 1,343 |
EBITDA | 2.9M 11M |
Recommendations | Buy |
|---|---|
12 Months Forecast | +67.05% upside |
Market Cap | -12M 214M |
|---|---|
Previous open | 22.26 |
Previous close | 16.72 |
Technical Score
By Trading Central
Confidence
Strong Bearish Evidence
STRATEC Biomedical AG Chart
Past performance is not a reliable indicator of future results.
Related News
Peer Comparison
Price change
STRATEC Biomedical AG Forecast
Price Target
By TipRanks
67.05% upside
12 Months Forecast
Average 29 EUR 67.05%
High 37 EUR
Low 21 EUR
Based on 2 Wall Street analysts offering 12 month price targets forSTRATEC Biomedical AG - Dist in the last 3 months.
Financials
Selling and administration expenses
Operating expenses
Pre-tax profit
Sales
Cost of sales
Gross profit on sales
Interest expense on debt
EBITDA
Operating profit
$
About STRATEC Biomedical AG
Stratec SE, together with its subsidiaries, designs and manufactures automation and instrumentation solutions in the fields of in-vitro diagnostics and life sciences in Germany, European Union, and internationally. It designs and manufactures automated analyzer systems for clinical diagnostics and biotechnology customers; and offers complex consumables for diagnostics and medical applications. The company was formerly known as STRATEC Biomedical AG and changed its name to Stratec SE in December 2018. Stratec SE was founded in 1979 and is headquartered in Birkenfeld, Germany.
